Back to Search
Start Over
Risk assessment of developmental and neurotoxicity by the flavoring agent perillaldehyde: NAC (N-acetylcysteine) mitigation of oxidative stress-mediated inhibition of the Nrf2 pathway.
- Source :
-
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP [Comp Biochem Physiol C Toxicol Pharmacol] 2025 Feb; Vol. 288, pp. 110071. Date of Electronic Publication: 2024 Nov 15. - Publication Year :
- 2025
-
Abstract
- Perillaldehyde (PAE), a prevalent flavoring agent, has raised safety concerns due to conflicting evidence regarding its toxicity. This study provides a comprehensive assessment of the developmental and neurotoxic effects of PAE in zebrafish, elucidating the underlying mechanisms of its toxicity. Results showed that PAE affected the viability and hatching rate of zebrafish at 96 h postfertilization with the 50 % lethal concentration (LC50) of 7.975 mg/L. Furthermore, exposed‌ to a non-lethal concentration of 4 mg/L PAE induced a spectrum of morphological abnormalities, such as pericardial edema, delayed yolk sac absorption, reduced body length, and microphthalmia. Behavioral observations revealed that PAE reduced motor ability, and was accompanied by an increase in spontaneous turning angle and angular velocity. Using the TG(elav13:EGFP) transgenic model, we observed the number of newborn neurons was reduced, indicating that PAE induced obvious neurotoxic effects. Additionally, this concentration facilitated the accumulation of reactive oxygen species (ROS) and malondialdehyde (MDA), concomitantly decreasing the activity of antioxidant enzymes. QRT-PCR analysis revealed that PAE down-regulated Nestin and Neurogenin1 gene expression, up-regulated Glipr1a and Nox1 gene expression, and inhibited the Nrf2/HO-1 pathway. Notably, co-administration of N-acetylcysteine (NAC), an inhibitor of oxidative stress, mitigated oxidative stress levels and partially ameliorated the neurotoxicity. These findings suggest that oxidative stress is the primary mediator of PAE-induced neurotoxicity. This study provides crucial insights for the safe application of PAE.<br />Competing Interests: Declaration of competing interest The authors declare that they have no conflicts of interest related to this study.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Flavoring Agents toxicity
Acrolein toxicity
Acrolein analogs & derivatives
Risk Assessment
Zebrafish Proteins metabolism
Zebrafish Proteins genetics
Neurotoxicity Syndromes prevention & control
Signal Transduction drug effects
Reactive Oxygen Species metabolism
Embryo, Nonmammalian drug effects
Animals, Genetically Modified
Antioxidants pharmacology
Monoterpenes
Zebrafish
Oxidative Stress drug effects
NF-E2-Related Factor 2 metabolism
NF-E2-Related Factor 2 genetics
Acetylcysteine pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1532-0456
- Volume :
- 288
- Database :
- MEDLINE
- Journal :
- Comparative biochemistry and physiology. Toxicology & pharmacology : CBP
- Publication Type :
- Academic Journal
- Accession number :
- 39549861
- Full Text :
- https://doi.org/10.1016/j.cbpc.2024.110071